The Valley Desk

NCT02032004 · Interventional trial

Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure

Overall registry status Completed

Phase 3

Conditions Chronic Heart Failure

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov